Moreover, CXCL8 produced by tumor cells or by CXCL8-transgenic mice gave rise to elevated osteolysis in vivo, whereas antibodies to CXCL8 prevented bone damage and elevated the survival of mice (146). Here, CXCL8 is linked to neoplasm.